1. Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studies

   • L. Aarons
   • M. Rowland
   • S. Vozeh

   Conference Report 01 January 1996 Pages: 251 - 254

2. Elderly patients' problems with medication

   • T. Nikolaus
   • W. Kruse
   • G. Schlierf

   Clinical Trials 01 January 1996 Pages: 255 - 259

3. Increased risk of ischaemic heart disease mortality in elderly men using anxiolytics-hypnotics and analgesics

   • J. Merlo
   • B. Hedblad
   • A. Melander

   Pharmacoepidemiology And Prescription 01 January 1996 Pages: 261 - 265

4. Lisinopril reduces postexercise albuminuria more effectively than atenolol in primary hypertension

   • C. R»ngemark
   • T. Hedner
   • L. Lindholm

   Pharmacodynamics 01 January 1996 Pages: 267 - 271

5. Tyramine pressor sensitivity in healthy subjects during combined treatment with moclobemide and selegiline

   • A. Korn
   • B. Wagner
   • E. Moritz

   Pharmacodynamics 01 January 1996 Pages: 273 - 278

6. Design of a suitable formulation of FK613, a novel antiallergic agent, based on its pharmacokinetic and pharmacodynamic properties in healthy subjects

   • T. Uematsu
   • S. Nagashima
   • A. Sugiyama

   Pharmacodynamics 01 January 1996 Pages: 279 - 284

7. A limited sampling method to estimate methotrexate pharmacokinetics in patients with rheumatoid arthritis using a Bayesian approach and the population data modeling program P-PHARM

   • F. Bressolle
   • L. Edno
   • R. Gomeni

   Pharmacokinetics And Disposition 01 January 1996 Pages: 285 - 292

8. Rectal pharmacokinetics of budesonide

   • K. Dahlström
   • S. Edsbäcker
   • A. Källén

   Pharmacokinetics And Disposition 01 January 1996 Pages: 293 - 298

9. Interindividual variability in the rate of salbutamol sulphation in the human lung

   • G. M. Pacifici
   • C. De Santi
   • C. A. Ageletti

   Pharmacokinetics And Disposition 01 January 1996 Pages: 299 - 303

10. Role of human liver microsomal CYP2C9 in the biotransformation of lornoxicam

    • P. Bonnabry
    • T. Leemann
    • P. Dayer

    Pharmacokinetics And Disposition 01 January 1996 Pages: 305 - 308

11. Biotransformation of caffeine by cDNA-expressed human cytochromes P-450

    • H. R. Ha
    • F. Follath
    • S. Krähenbühl

    Pharmacokinetics And Disposition 01 January 1996 Pages: 309 - 315

12. Increase in magnesium plasma level after orally administered trimagnesium dicitrate

    • C. Wilimzig
    • R. Latz
    • S. Nyulassy

    Pharmacokinetics And Disposition 01 January 1996 Pages: 317 - 323

13. A pharmacokinetic-pharmacodynamic model for a muscle relaxant: atracurium

    • V. Nigrovic
    • J. Gaspari
    • M. Banoub

    Pharmacokinetics And Disposition 01 January 1996 Pages: 325 - 332

14. Book review

    • Lloyd R. Kèlland

    BookReview 01 January 1996 Pages: 333 - 334

15. Announcements

    Announcement 01 January 1996 Pages: 334 - 334